Industry Reports

LEO Pharma and Bayer announced the completion of the relevant closing conditions to allow the transfer of Bayer’s prescription dermatology business to LEO Pharma in the United States.…
Read More...

Novartis announced it has agreed to sell selected portions of its Sandoz US portfolio, specifically the Sandoz US dermatology business and generic US oral solids portfolio, to Aurobindo…
Read More...

Sanofi has reached a civil settlement with the U.S. Securities and Exchange Commission (SEC) fully resolving the SEC’s investigation into possible violations of the U.S. Foreign Corrupt…
Read More...

NovellusDx and Primetech announce that Primetech will provide NovellusDx' functional genomics assay "FACT – Functional Annotation for Cancer Treatment" as an exclusive dealer in Japan…
Read More...

Evox Therapeutics Ltd announces that it has raised £35.5 million ($45.4 million) of new capital in a Series B financing round. Redmile Group led the financing with significant new…
Read More...

Longeveron LLC, a biopharmaceutical company that develops stem cell therapies for aging-related diseases, announced that the company has appointed Arin Maercks as chief commercial…
Read More...

UPM Pharmaceuticals, a Contract Development and Manufacturing Organization (CDMO) focused on oral solid and semi-solid drug dosage forms, has appointed Dr. Chi-Chang Wung to the…
Read More...

Sirona Biochem Corp. announced that it has received the $500,000 USD milestone payment from partner Wanbang Biopharmaceuticals Co., Ltd for approval by the China Food and Drug…
Read More...

PTC Therapeutics announced that it has successfully completed the acquisition of Agilis Biotherapeutics, Inc., a private biotechnology company focused on the advancement of innovative…
Read More...

Almac Group has announced the appointment of Jonothan Cooil to Vice President of Engineering, Facilities and Health, Safety & Environment. He will report to Almac Group CEO, Alan…
Read More...

The Centre for the Commercialization of Antibodies and Biologics (CCAB) and ImmunoBiochem Corporation have announced an agreement that will see CCAB provide a new investment to help…
Read More...

AgeX Therapeutics, Inc., a subsidiary of BioTime, Inc. announced that it has acquired certain patents and patent applications from Escape Therapeutics relating primarily to the use of…
Read More...

Biopharmaceutical company Emalex Biosciences (Emalex), the newest member of the Paragon Biosciences (Paragon) portfolio of companies, today announced it acquired Psyadon Pharmaceuticals…
Read More...

Cancer Prevention Pharmaceuticals announced the signing of a license agreement with Mallinckrodt Pharmaceuticals, through its Sucampo AG subsidiary, wherein Mallinckrodt obtained…
Read More...

Astellas Pharma Inc. and Quethera Limited announced that Astellas has acquired Quethera, a gene therapy company headquartered in the United Kingdom, that is focused on developing novel…
Read More...

PaxVax announced that it has entered into a definitive agreement to be acquired by Emergent BioSolutions. PaxVax is majority owned by an affiliate of Cerberus Capital Management, a…
Read More...

Perrigo Company plc announced that its Board of Directors approved a plan to separate the Company's Prescription Pharmaceuticals (Rx) business following the Company's previously…
Read More...

OvaScienceSM and privately-held Millendo Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing novel treatments for orphan endocrine diseases, announced…
Read More...

Apexigen, Inc., a clinical-stage biopharmaceutical company, announced the successful completion of its Series B and Series C financings in which it raised a total of $73 million. The…
Read More...

Tanner Pharma Group has announced the signing of a distribution agreement with Nephcentric LLC, a developer and marketer of evidence based therapeutic options for people with kidney…
Read More...